These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3914866)
21. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei. Rui X; Xu Y; Wan H; Su G; Huang C Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355 [TBL] [Abstract][Full Text] [Related]
22. [Membrane component of Shigella flexneri and their relationship to bacteria antigenicity and virulence]. Jin L; Su X Wei Sheng Wu Xue Bao; 1990 Feb; 30(1):48-53. PubMed ID: 2188429 [TBL] [Abstract][Full Text] [Related]
23. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein]. Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161 [TBL] [Abstract][Full Text] [Related]
24. Vaccine potential for inactivated shigellae. Osorio M; Bray MD; Walker RI Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431 [TBL] [Abstract][Full Text] [Related]
25. [Study of intestinal infections in experiments on monkeys]. Dzhikidze EK; Kavtaradze KN; Stasilevich ZK; Shaginian SA; Gvazava IS Vestn Akad Med Nauk SSSR; 1977; (8):59-65. PubMed ID: 410189 [No Abstract] [Full Text] [Related]
26. Bacteriological and epidemiological approaches to the prophylaxis of enteric infection. VI. In vitro studies on the mechanism of acquired resistance to Shigella flexneri infection (1). Sakaguchi T; Sakaguchi S; Okamoto M; Matsui S; Anzai H Kitasato Arch Exp Med; 1980 Dec; 53(3-4):97-109. PubMed ID: 7035741 [No Abstract] [Full Text] [Related]
27. Effect of outer membrane proteins (OMP) of Shigella on interleukin 2 (IL-2) production by spleen cells of mice. Czarny A; Witkowska D; Mulczyk M Arch Immunol Ther Exp (Warsz); 1994; 42(3):159-61. PubMed ID: 7487346 [TBL] [Abstract][Full Text] [Related]
28. An approach to chimeric subunit immunogen provides efficient protection against toxicity, type III and type v secretion systems of Shigella. Felegary A; Nazarian S; Kordbacheh E; Fathi J; Minae ME Int Immunopharmacol; 2021 Nov; 100():108132. PubMed ID: 34508943 [TBL] [Abstract][Full Text] [Related]
29. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals. Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598 [No Abstract] [Full Text] [Related]
30. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies. Camacho AI; Souza-Rebouças J; Irache JM; Gamazo C Methods; 2013 May; 60(3):264-8. PubMed ID: 23046911 [TBL] [Abstract][Full Text] [Related]
32. Effect of outer membrane proteins of Shigella on delayed hypersensitivity in mice to sheep red blood cells. Czarny A; Witkowska D; Mulczyk M Arch Immunol Ther Exp (Warsz); 1987; 35(4):439-46. PubMed ID: 3326545 [TBL] [Abstract][Full Text] [Related]
33. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model. Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492 [TBL] [Abstract][Full Text] [Related]
34. Outer membrane protein A (OmpA) from Shigella flexneri 2a: a promising subunit vaccine candidate. Pore D; Chakrabarti MK Vaccine; 2013 Aug; 31(36):3644-50. PubMed ID: 23764536 [TBL] [Abstract][Full Text] [Related]
35. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Bangtrakulnonth A; Vieira AR; Lo Fo Wong DM; Pornreongwong S; Pulsrikarn C; Sawanpanyalert P; Hendriksen RS; Aarestrup FM Foodborne Pathog Dis; 2008 Dec; 5(6):773-84. PubMed ID: 19086804 [TBL] [Abstract][Full Text] [Related]
36. Phagocytic and bactericidal properties of macrophages of mice immunized with outer membrane proteins (OMP) of Shigella. Czarny A; Witkowska D; Mulczyk M Arch Immunol Ther Exp (Warsz); 1988; 36(6):701-9. PubMed ID: 3254119 [TBL] [Abstract][Full Text] [Related]